Literature DB >> 16472776

Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.

Lirong Peng1, Genglin Jin, Li Wang, Jianpin Guo, Lin Meng, Chengchao Shou.   

Abstract

PRL-3 is a newly identified protein tyrosine phosphatase associated with tumor metastasis. It is over-expressed in various cancers, such as colorectal cancer, gastric cancer, and ovarian cancer, and is correlated with the progression and survival of cancers. Although PRL-3 plays a causative role in promoting cancer cell invasion and metastasis, the molecular mechanism is unknown. To investigate PRL-3's roles in tumorigenesis and signal transduction pathway, we screened the human placenta brain cDNA library with the bait of PRL-3 in yeast two-hybrid system. Then we identified integrin alpha1 as a PRL-3-interacting protein for the first time, and verified this physical association with pull-down and co-immunoprecipitation assays. Furthermore, we found that PRL-3 could down-regulate the tyrosine-phosphorylation level of integrin beta1 and increased the phosphorylation level of Erk1/2. Our present discovery will provide new clues for elucidating the molecular mechanism of PRL-3 in promoting cancer invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472776     DOI: 10.1016/j.bbrc.2006.01.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.

Authors:  Ru-Tian Hao; Xiao-Hua Zhang; Yi-Fei Pan; Hai-Guang Liu; You-Qun Xiang; Li Wan; Xiu-Ling Wu
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

Review 2.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

Review 3.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 4.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

5.  PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.

Authors:  Feng Qian; Yu-Pei Li; Xia Sheng; Zi-Chao Zhang; Ran Song; Wei Dong; Shao-Xian Cao; Zi-Chun Hua; Qiang Xu
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

6.  Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.

Authors:  Ni Dai; Ai-Ping Lu; Cheng-Chao Shou; Ji-You Li
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

7.  Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.

Authors:  Chad D Walls; Anton Iliuk; Yunpeng Bai; Mu Wang; W Andy Tao; Zhong-Yin Zhang
Journal:  Mol Cell Proteomics       Date:  2013-09-12       Impact factor: 5.911

8.  Functional analysis of the cytoplasmic domain of the integrin {alpha}1 subunit in endothelial cells.

Authors:  Tristin D Abair; Nada Bulus; Corina Borza; Munirathinam Sundaramoorthy; Roy Zent; Ambra Pozzi
Journal:  Blood       Date:  2008-07-22       Impact factor: 22.113

9.  Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.

Authors:  Unn-Merete Fagerli; Randi U Holt; Toril Holien; Thea K Vaatsveen; Fenghuang Zhan; Kjartan W Egeberg; Bart Barlogie; Anders Waage; Harald Aarset; Hong Yan Dai; John D Shaughnessy; Anders Sundan; Magne Børset
Journal:  Blood       Date:  2007-10-12       Impact factor: 22.113

10.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.